Convergent Solution-Phase Combinatorial Synthesis
J . Org. Chem., Vol. 64, No. 19, 1999 7099
(1.5 mL) and treated with m-iodobenzoic acid (C1, 41.9 mg,
0.169 mmol), PyBrOP (79 mg, 0.169 mmol), and i-Pr2NEt (88
µL, 0.507 mmol). After 18 h of stirring at 25 °C, the reaction
mixture was diluted with EtOAc (50 mL) and washed with
10% aqueous HCl (3 × 50 mL), saturated aqueous NaHCO3
(50 mL), and saturated aqueous NaCl (50 mL). Drying (Na2-
SO4) and concentration provided 4 as a white foam (63 mg,
68%): 1H NMR (CDCl3, 250 MHz) δ 7.75 (m, 2H), 7.28 (m,
6H), 7.18 (m, 2H), 7.10 (m, 1H), 6.85 (m, 2H), 3.86 (br s, 4H),
3.76 (s, 3H), 3.61 (m, 4H), 2.85 (m, 4H); IR (film) νmax 3274,
3062, 2932, 2834, 1651, 1558, 1512, 1454, 1398, 1372, 1331,
1301, 1247, 1196, 1178, 1033, 1009, 958, 914, 803, 750, 735,
700 cm-1; FABHRMS (NBA-CsI) m/z 732.0359 (M + Cs+,
C
28H30N3O4I requires 732.0335).
Characterization data for 5-13 may be found in Supporting
Information.
Gen er a l P r oced u r e for th e Syn th esis of In d ivid u a l
Dia r yla cetylen es, P r ep a r a tion of 14. Iodide 4 (14.4 mg,
0.024 mmol), bis(tributylstannyl)acetylene (7.24 mg, 0.012
mmol), and tetrakis(triphenylphosphine)palladium (1.38 mg,
0.0012 mmol) were dissolved in dioxane (0.2 mL). Three
crystals of BHT (2,6-di-tert-butyl-4-methylphenol) were added,
and the reaction mixture was stirred at 100 °C for 5 h. The
solvent was evaporated and chromatography (SiO2, 50% EtOH/
EtOAc) afforded 14 as a colorless oil (7.0 mg, 60%): 1H NMR
(CDCl3, 250 MHz) δ 7.90-6.95 (m, 22H), 6.75 (m, 4H), 3.90-
3.40 (m, 22H), 3.20-2.60 (m, 8H); IR (film) νmax 3274, 3064,
2933, 1652, 1558, 1539, 1512, 1456, 1398, 1301, 1246, 1178,
1112, 1087, 1033, 957, 806, 750, 699 cm-1; FABHRMS (NBA-
CsI) m/z 1101.3583 (M + Cs+, C58H60N6O8 requires 1101.3527).
Characterization data for 15-23 may be found in Support-
ing Information.
Syn th esis of a 15-Com p on en t Dia r yla cetylen e Su bli-
br a r y. An equimolar solution of m-iodobenzamides 4 and 6-9
(0.004 mmol each, 0.020 mmol total) in 0.4 mL dioxane was
treated with bis(tributylstannyl)acetylene (6.0 mg, 0.010
mmol), Pd(PPh3)4 (11.4 mg, 0.0010 mmol), and three crystals
of BHT and stirred at 100 °C for 5 h. The solvent was
evaporated and chromatography (SiO2, 5-50% EtOH/EtOAc)
1
afforded the sublibrary as a yellow oil (7.2 mg, 63%). The H
NMR spectrum was consistent with the desired product
mixture, and the mass spectrum exhibited all predicted
molecular ions (15 components which have 14 unique molec-
ular weights): ESMS (M + Na+) m/z 991, 1048, 1076, 1104,
1105, 1133, 1161, 1174, 1189, 1217, 1231, 1259, 1287, 1357.
The mixture Stille coupling of p-iodobenzamides 10-13
under identical conditions afforded the expected 10-component
product mixture (9 unique molecular weights) in 47% yield:
ESMS (M + Na+ or M + H+) m/z 1107, 1134, 1162, 1190, 1218,
1231, 1260, 1290, 1335.
F igu r e 5. Comparison of the 1H NMR (CDCl3) spectra of 3,
8, 17, and 28.
Mixtu r e Stille Cou p lin g betw een Meta a n d P a r a
Su bstr a tes (7 a n d 12). A solution of iodobenzamides 7 (4.0
mg, 5.85 µmol) and 12 (4.5 mg, 6.32 µmol) in dioxane (0.3 mL)
was treated with bis(tributylstannyl)acetylene (3.7 mg, 6.1
µmol), Pd(PPh3)4 (0.7 mg, 0.61 µmol), and three crystals of
BHT, and stirred at 100 °C for 5 h. The solvent was evaporated
and chromatography (SiO2, 5-50% EtOH/EtOAc) afforded the
product mixture as a yellow oil (3.0 mg, 42%). The 1H NMR
spectrum was consistent with a 1:1:2 mixture of products 16,
22, and 24, and MS analysis confirmed the presence of all three
molecular ions: ESMS (M + Na+) m/z 1161, 1189, 1218.
mmol) and 4-methoxyphenethylamine (0.21 g, 1.42 mmol).
PyBOP (0.74 g, 1.42 mmol) was added, and the reaction
mixture was stirred for 16 h at 25 °C and then poured into a
separatory funnel containing 50 mL of 10% aqueous HCl and
extracted into EtOAc (3 × 50 mL). The combined organic
phases were washed with 10% aqueous HCl (2 × 50 mL),
saturated aqueous NaHCO3 (2 × 50 mL), and saturated
aqueous NaCl (50 mL), dried (Na2SO4), and concentrated to
provide 0.55 g (94%) of 3 as a colorless oil (see Figure 5 for a
1
comparison of H NMR spectra): 1H NMR (CDCl3, 250 MHz)
δ 7.29-7.08 (m, 7H), 6.81 (d, 2H, J ) 8.5 Hz), 3.74 (m, 7H),
3.50 (m, 4H), 2.80 (m, 4H), 1.38 (s, 9H); IR (film) νmax 3243,
3066, 2974, 2932, 1700, 1652, 1558, 1513, 1456, 1394, 1367,
1247, 1175, 1140, 1033, 960, 894, 846, 751, 700 cm-1; FAB-
HRMS (NBA-NaI) m/z 470.2651 (M + H+, C26H35N3O5 re-
quires 470.2655).
Gen er a l P r oced u r e for th e Th ir d Diver sifica tion ,
In d ivid u a l Com p on en ts. P r ep a r a tion of N-(3-iod oben -
zoyl)-N′-(2-p h en yleth yl)-N′′-(2-(4-m eth oxyp h en yl)eth yl)-
im in od ia cetic Acid Dia m id e (4). The BOC derivative 3 (71
mg, 0.15 mmol) was stirred in 4 N HCl-dioxane (1.0 mL) for
2 h. Solvent and excess acid were removed under a stream of
N2, and the remaining crude HCl salt was dissolved in DMF
Gen er a l P r oced u r e for th e Syn th esis of In d ivid u a l
Bia r yls, P r ep a r a tion of 30. Iodide 5 (10.6 mg, 17.7 mmol)
was mixed with 10% Pd/C (1.8 mg, 1.77 mmol) and Et3N (3.2
µL, 25.8 mmol) in DMF (90 µL, 0.2 M) and stirred at 100 °C
for 18 h. The solvent was evaporated and chromatography
(SiO2, 5-50% EtOH/EtOAc) afforded 30 as a pale yellow foam
(5.4 mg, 64%): 1H NMR (CDCl3, 250 MHz) δ 7.48 (m, 4H),
7.38 (m, 4H), 7.25 (m, 10H), 7.18 (m, 4H), 6.86 (m, 4H), 3.89
(m, 8H), 3.75 (m, 6H), 3.55 (m, 8H), 2.85 (m, 8H); IR (film)
νmax 3281, 3063, 2930, 1650, 1565, 1512, 1454, 1400, 1301,
1246, 1178, 1087, 1032, 1000, 910, 834, 730, 699 cm-1
;
FABHRMS (NBA-CsI) m/z 1077.3488 (M + Cs+, C56H60N6O8
requires 1077.3527).